The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Risk of Alzheimer's disease and duration of NSAID use
Open accessAbstract
In a longitudinal study of 1,686 participants in the Baltimore Longitudinal Study of Aging, we examined whether the risk of Alzheimer's disease (AD) was reduced among reported users of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). In addition, we examined use of acetaminophen, a pain-relief medication with little or no anti-inflammatory activity, to assess the specificity of the association between AD risk and self-reported medications. Information on use of medications was collected during each biennial examination between 1980 and 1995. The relative risk (RR) for AD decreased with increasing duration of NSAID use. Among those with 2 or more years of reported NSAID use, the RR was 0.40 (95% confidence interval [CI]: 0.19-0.84) compared with 0.65 (95% CI: 0.33-1.29) for those with less than 2 years of NSAID use. The overall RR for AD among aspirin users was 0.74 (95% CI: 0.46-1.18), and no trend of decreasing risk of AD was observed with increasing duration of aspirin use. No association was found between AD risk and use of acetaminophen (RR = 1.35; 95% CI: 0.79-2.30), and there was no trend of decreasing risk with increasing duration of use. These findings are consistent with evidence from cross-sectional studies indicating protection against AD risk among NSAID users and with evidence suggesting that one stage of the pathophysiology leading to AD is characterized by an inflammatory process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The recognition that a robust inflammatory response contributes to AD also fuelled the discovery that long-term treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) reduced the risk for AD, delayed disease onset, and slowed cognitive decline (McGeer et al., 1996;Stewart et al., 1997;in t' in t'Veld et al., 2001).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Stewart et al., 1997
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
Bayes Estimates for the Linear Model
Lindley, D. V., & Smith, A. F. M. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00885.x · Cited by 2,025
Normal Human Aging: The Baltimore Longitudinal Study on Aging
Shock, N. W., Greulich, R. C., Costa, P. T., Andres, R., Lakatta, E. G., Arenberg, D., & Tobin, J. D. (1984) · University Libraries (University of Maryland) · doi:10.13016/sclw-iccq · Cited by 757
Inverse association of anti‐inflammatory treatments and Alzheimer's disease
Breitner, J. C. S., Gau, B. A., Welsh-Bohmer, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J., & Anthony, J. C. (1994) · Neurology · doi:10.1212/wnl.44.2.227 · Cited by 569
Activation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383
Stremmel, W., Strohmeyer, G. W., Borchard, F., Kochwa, S., & Berk, P. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.4 · Cited by 350
A Population-Based Study of the Risk of Recurrence of Birth Defects
Lie, R. T., Wilcox, A. J., & Skjærven, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310101 · Cited by 164
Cohler, B. J., ROBBINS, D. M., Hartman, C. R., Shader, R. I., Grunebaum, H. U., Gallant, D. H., & Weiss, J. L. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90017-5 · Cited by 132
The need for multiple time points in aging studies
Coleman, P. A., Finch, C. E., & Joseph, J. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90055-5 · Cited by 66
Research works printed but not linked: 16
- Altstiel L, Sperber K. Cytokines in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:481-495.
- Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques: an immunohistochemical study. Acta Neuropathol (Berl) 1982;57:239-252.
- Anonymous. The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
- Lucca U, Tettamanti M, Forloni G, Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994;36:854-856.
- Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology 1995;45:1441-1445.
- Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
- Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
- Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn 1992;18:70-87.
- Morris JC, Mohs R, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a Registry for Alzheimer's Disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652.
- Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
- Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.
- Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence using the New Adult Reading Test. Cortex 1978;14:234-244.
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
- Checkoway H Pearce NE Crawford-Brown DJ. Research methods in occupational epidemiology monographs in epidemiology and biostatistics vol 13. New York: Oxford University Press 1989:153-155.
- Aspirin Myocardial Infarction Study Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980;243:661-669.
- Paulas HE. Nonsteroidal anti-inflammatory drugs. In: Kelley WN Harris ED Ruddy S Sledge CB eds. A textbook of rheumatology. Philadelphia: WB Saunders 1989.
Cited by
Sorted by citations
Items 801–900 of 1,000
Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β
Anastasio, T. J. (2014) · Molecular BioSystems · doi:10.1039/c4mb00457d · Cited by 11
Muñoz, Ú., Cuevas, N. D. L., Bartolomé, F. B., Hermida, O. G., Bermejo, F., & Martín‐Requero, Á. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.010 · Cited by 11
The Alzheimer Pandemic: Is Paracetamol to Blame?
Jones, G. R. N. (2014) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528112666131219163405 · Cited by 11
Cholinergic deficiency in Alzheimer's disease. Pathogenic model.
Schneider, L. S. (1998) · The American journal of geriatric psychiatry · doi:10.1097/00019442-199821001-00007 · Cited by 12
Iwata, R., Kitagawa, K., Zhang, N., Wu, B., & Inagaki, C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.103 · Cited by 11
Staats, P. S. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00413-x · Cited by 11
Therapeutics of Ibuprofen in Rheumatic and Other Chronic and Painful Diseases
Kean, W. F., Rainsford, K. D., & Buchanan, W. W. (2015) · Wiley eBooks · doi:10.1002/9781118743614.ch6 · Cited by 12
Genetic Testing for Alzheimer Disease
Tracy, K. B. (1997) · JAMA · doi:10.1001/jama.1997.03550120038022 · Cited by 11
The Cyclooxygenase-2 Theory of Atopy and Asthma
Varner, A. E. (1999) · Pediatric Asthma Allergy & Immunology · doi:10.1089/pai.1999.13.43 · Cited by 11
Prevention of Alzheimer's disease
Parfenov, V. A. (2011) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2011-159 · Cited by 11
Dementia in Germany: Past Trends and Future Developments
Ziegler, U. (2011) · DZNE Pub · doi:10.18453/rosdok_id00000815 · Cited by 11
Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease
Léger, G. C., & Massoud, F. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.811237 · Cited by 10
Current Conceptual View of Alzheimer’s Disease
Herrup, K. (2012) · Advances in biological psychiatry · doi:10.1159/000335378 · Cited by 10
Iso-α-Acids, the Bitter Components of Beer, Suppress Microglial Inflammation in rTg4510 Tauopathy
Ano, Y., Takaichi, Y., Uchida, K., Kondô, K., Nakayama, H., & Takashima, A. (2018) · Molecules · doi:10.3390/molecules23123133 · Cited by 10
Is Alzheimer's Disease a Synaptic Disorder?
Pomponi, M., Bria, P., & Pomponi, M. F. L. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13104 · Cited by 10
Prevention of Alzheimer’s disease: Where we stand
Sano, M. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0064-8 · Cited by 10
In vitrostudy of fenoprofen chiral inversion in rat: comparison of brain versus liver
Sevoz, C., Cottet‐Rousselle, C., Benoît, E., & Buronfosse, T. (1999) · Xenobiotica · doi:10.1080/004982599238074 · Cited by 10
Imamura, K., Sawada, M., Ozaki, N., Naito, H., Iwata, N., Ishihara, R., Takeuchi, T., & Shibayama, H. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200101000-00006 · Cited by 11
Schachter, A. S., & Davis, K. L. (2000) · Current Treatment Options in Neurology · doi:10.1007/s11940-000-0023-0 · Cited by 13
Love, R., Salazar, G., & Faúndez, V. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.018 · Cited by 10
Evidence‐based pharmacological treatment of dementia
Emre, M., & Hanagasi, H. A. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00055.x · Cited by 10
Ramey, S. L., & Ramey, C. T. (1999) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/(sici)1098-2779(1999)5:1 · Cited by 48
Detangling Alzheimer's Disease
Helmuth, L. L. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.43.oa2 · Cited by 10
Chierichetti, M., Cristofani, R., Crippa, V., Ferrari, V., Cozzi, M., Casarotto, E., Pramaggiore, P., Cornaggia, L., Patelli, G., Mohamed, A. A., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00517 · Cited by 10
Asthana, A., Tripathi, S., & Agarwal, R. (2024) · Neurology India · doi:10.4103/ni.ni_1073_22 · Cited by 9
Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
Womack, T., Vollert, C. T., Ohia-Nwoko, O., Schmitt, M. E., Montazari, S., Beckett, T. L., Mayerich, D. M., Murphy, M. P., & Eriksen, J. L. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.769347 · Cited by 8
Cell cycle and Alzheimer's disease: studies in non-neuronal cells
Cuevas, N. D. L., Muñoz, Ú., Bartolomé, F. B., Esteras, N., Alquézar, C., & Martín‐Requero, Á. (2010) · Journal of Applied Biomedicine · doi:10.2478/v10136-009-0015-7 · Cited by 9
NONSTEROIDAL ANTIINFLAMMATORY DRUGS
Pepper, G. A. (2000) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02456-2 · Cited by 9
Mackowiak, P. A. (2000) · Clinical Infectious Diseases · doi:10.1086/317509 · Cited by 9
Chronic Intracerebral LPS as a Model of Neuroinflammation
Wenk, G. L., & Hauss‐Wegrzyniak, B. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-297-5_6 · Cited by 9
Medication Exposure and Risk of Dementia and Alzheimer’s Disease
Sharma, N., An, S. S. A., & Kim, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312850 · Cited by 10
Chloroquine, the Coronavirus Crisis, and Neurodegeneration: A Perspective
Pedrioli, G., Patani, R., & Paganetti, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.596528 · Cited by 8
Li, P., Ye, L., Sun, S., Wang, Y., Chen, Y., Chang, J., Yin, R., Liu, X., Zuo, W., Xu, H., et al. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01503-8 · Cited by 7
Reduced DNA oxidation in aged prostaglandin H synthase-1 knockout mice
Jeng, W., Ramkissoon, A., & Wells, P. G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.016 · Cited by 8
Maggioli, E., Boiocchi, C., Zorzetto, M., Sinforiani, E., Cereda, C., Ricevuti, G., & Cuccia, M. (2013) · Current Alzheimer Research · doi:10.2174/15672050113106660169 · Cited by 8
Voigt, R. M., Raeisi, S., Yang, J., Leurgans, S. E., Forsyth, C. B., Buchman, A. S., Bennett, D. A., & Keshavarzian, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0240342 · Cited by 9
Gholami, M., Sadegh, M., Koroush-arami, M., Norouzi, S., Arismani, R. J., Asadi, E., Amini, M., & Khodayari, N. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01347-1 · Cited by 8
Inflammation and the pathophysiology of Alzheimer's disease
Murphy, G. M. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.3/mgreer · Cited by 9
Park, S. A., Chevallier, N., Tejwani, K., Hung, M. M., Maruyama, H., Golde, T. E., & Koo, E. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.015 · Cited by 8
McLarnon, J. G. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191106095038 · Cited by 8
NSAIDs and Alzheimer’s disease: contribution of observational epidemiologic studies
Launer, L. J., & Veld, B. A. I. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00103-1 · Cited by 8
Koivisto, A. M. (2006) · Cited by 8
Glial and Neuronal Expression of Cyclooxygenase-2: Relevance to Alzheimer’S Disease
O’Banion, M. K., Chang, J. W., Kaplan, M. D., Yermakova, A., & Coleman, P. D. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1810-9_36 · Cited by 8
Neuroinflammation and oxidative injury in developmental neurotoxicity
Milatović, D., Zaja‐Milatovic, S., Brockett, M. M., BREYER, R. M., Aschner, M., & Montine, T. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00056-4 · Cited by 7
Kang, E. Y., Kim, D., Kim, H. K., Shin, W., Park, Y., Kim, T. H., Kim, W., Cao, L., Lee, S. G., Gang, G., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300329 · Cited by 8
Park, M., Jung, Y. S., Park, J. H., Choi, Y. W., Lee, J., Kim, C. M., Baek, J. U., Choi, B. T., & Shin, H. K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/768049 · Cited by 7
Smith, K. J., & Skelton, H. G. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-001-0047-4 · Cited by 7
Development of antiinflammatory therapy for Alzheimer's disease
Aisen, P. S. S. (2002) · Drug Development Research · doi:10.1002/ddr.10094 · Cited by 7
Janciauskiene, S. M., Sun, Y., & Wright, H. T. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0519 · Cited by 7
New Research Directions in Neuroepidemiology
Cowan, L. D., Leviton, A., & Dammann, O. (2000) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a018018 · Cited by 8
Innate Inflammatory Reaction of the Brain in Alzheimer Disease
McGeer, E. G., & McGeer, P. L. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v3i2.543 · Cited by 8
Drugs for the prevention and treatment of Alzheimer's disease
Brodaty, H., & Sachdev, P. S. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb126661.x · Cited by 7
Alzheimer s disease and brain development common molecular pathways
Bowser, R. P. (1998) · Frontiers in bioscience · doi:10.2741/a267 · Cited by 7
Alzheimer’s disease: transgenic mouse models and drug assessment
Yu, P., & Oberto, G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0670 · Cited by 7
In vitro effect of selected medicinal plants on β-amyloid induced toxicity in neuroblastoma cells
Adewusi, E. A. (2012) · UpSpace Institutional Repository (University of Pretoria) · Cited by 7
The Ubiquitin/Proteasome Pathway in Neurological Disorders
Figueiredo‐Pereira, M. E., & Rockwell, P. (2002) · Springer eBooks · doi:10.1007/0-306-46847-6_10 · Cited by 7
Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease
Oh, C.-K., Wang, Y., & Lipton, S. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00707 · Cited by 6
Huang, X., Huang, L., Tan, C., Wei, J.-M., Zhang, X.-H., Tan, L., & Xu, W. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13434-0 · Cited by 6
Asthana, A., Tripathi, S., & Agarwal, R. (2023) · Advances in Alzheimer s Disease · doi:10.4236/aad.2023.121001 · Cited by 6
Vasco, V. R. L. (2023) · OBM Geriatrics · doi:10.21926/obm.geriatr.2302234 · Cited by 6
Dileep, K. V., Remya, C., Tintu, I., & Sadasivan, C. (2013) · Frontiers in Life Science · doi:10.1080/21553769.2014.901924 · Cited by 7
Pharmacology and Clinical action of Cox-2 Selective Nsaids
Bovill, J. G. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9192-8_18 · Cited by 6
Ursachen und Behandlungskonzepte der Demenzen
Förstl, H., Lauter, H. J., & Bickel, H. (2001) · VS Verlag für Sozialwissenschaften eBooks · doi:10.1007/978-3-322-99712-8_4 · Cited by 6
Fukami, S., Iwata, N., & Saido, T. C. (2002) · Drug Development Research · doi:10.1002/ddr.10073 · Cited by 5
Managing Alzheimer Dementia Tomorrow
Rosenthal, T. C., & Khotianov, N. (2003) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.16.5.423 · Cited by 7
Non-steroidal anti-inflammatory drugs
Botting, R. M., & Botting, J. H. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7408-x_27 · Cited by 6
Silva, A. M., & Reis, L. F. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005887200 · Cited by 6
Understanding Genetic Testing for Alzheimer Disease: Medical and Epidemiological Background
McCONNELL, L. M. (1999) · Genetic Testing · doi:10.1089/gte.1999.3.21 · Cited by 6
Dissecting the relative influences of genes and the environment in Alzheimer's disease
Mayeux, R. P. (2004) · Annals of Neurology · doi:10.1002/ana.20037 · Cited by 6
Pasinetti, G. M., HO, L., & Pompl, P. N. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00007-6 · Cited by 6
Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Romero‐Márquez, J. M., Navarro‐Hortal, M. D., Varela‐López, A., Calderón‐Iglesias, R., Puentes, J. G., Giampieri, F., Battino, M. A., Sánchez‐González, C., Xiao, J., García‐Ruiz, R., et al. (2025) · Food Frontiers · doi:10.1002/fft2.70013 · Cited by 6
Modelling of anti-inflammatory treatment in the Alzheimer disease: optimal regimen and outcome
Hajj, W. E., Pujo-Menjouet, L., Tine, L. M., & Volpert, V. A. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-025-01553-8 · Cited by 3
Inflammatory Processes Exacerbate Degenerative Neurological Disorders
McGeer, P. L., McGeer, E. G., & Schwab, C. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_10 · Cited by 6
Pontiki, E. A., Kontogiorgis, C. A., Xu, Y., Hadjipavlou‐Litina, D., & Luo, Y. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-120940 · Cited by 5
Does General Anesthesia Promote Alzheimer’s disease?
Hauck, J. N. (2012) · Journal of Anesthesia & Clinical Research · doi:10.4172/2155-6148.1000193 · Cited by 5
Dementia: pharmacological and non-pharmacological treatments and guideline review
Simard, M., & Sampson, E. L. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.013 · Cited by 5
Morin-Alain, V., Larouche, E., Chouinard, A.-M., Audet, M.-C., Goulet, S., Rousseau, L.-S., & Hudon, C. (2020) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2002022 · Cited by 3
Neuroprotective mechanisms of Ginkgo biloba against oxidative stress
Cheung, H. M., & Yew, D. T. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817780-8.00018-9 · Cited by 5
Structural Characterization of Multicomponent Crystals Formed from Diclofenac and Acridines
Mirocki, A., & Sikorski, A. (2022) · Materials · doi:10.3390/ma15041518 · Cited by 5
Association between aspirin use and risk of dementia: a systematic review and meta-analysis
Tao, T., Feng, G., & Fang, Y. (2023) · European Geriatric Medicine · doi:10.1007/s41999-023-00877-9 · Cited by 5
Mhatre, M., & Hensley, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50155-1 · Cited by 4
Drug treatment for early Alzheimer's disease
Bullock, R. A. (1998) · Advances in Psychiatric Treatment · doi:10.1192/apt.4.3.126 · Cited by 5
Neurodegenerative diseases and memory
Wenk, G. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012372540-0/50017-0 · Cited by 5
Non-steroidal anti-inflammatory drugs (NSAIDs)
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01165-3 · Cited by 5
Statin–Alzheimer Disease Association Not Yet Proven
Lesser, G. T., & Libow, L. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.6.1022-a · Cited by 5
Processo Inflamatório e Neuroimunomodulação na Doença de Alzheimer
Rocha, N. P., Martins, L. D. C. A., Teixeira, A. L., & Reis, H. J. (2001) · Revista Neurociências · doi:10.34024/rnc.2011.v19.8385 · Cited by 24
Bullock, R. A. (2008) · Psychiatry · doi:10.1016/j.mppsy.2007.11.001 · Cited by 4
Carlucci, G. (2009) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152309787580829 · Cited by 4
Attempts at suppression of amyloidogenesis in a mouse model by a variety of anti-inflammatory agents
Shtrasburg, S., Pras, M., Rabinovich, E., Gal, R., Livneh, A., & Lidar, M. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.017 · Cited by 4
Are Inflammatory Profiles the Key to Personalized Alzheimer's treatment?
Brothers, H. M., & Wilcock, D. M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.40 · Cited by 3
Kielian, T., & Drew, P. D. (2005) · Humana Press eBooks · doi:10.1385/1-59259-905-2:041 · Cited by 4
Li, C., Liu, K., Zhu, J., & Zhu, F. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00366-4 · Cited by 6
Posttraumatic epilepsy: Diagnosis and treatment
Grinenko, O., Зайцев, О. С., Oknina, L. B., Ураков, С. В., Головтеев, А. Л., & Aa, P. (2011) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2011-160 · Cited by 4
Botting, R. M., & Botting, J. H. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7879-1_1 · Cited by 4
Agregados amiloides: rol en desórdenes de conformación proteica
Duran-Aniotz, C. A., Moreno‐González, I., & Morales, R. (2013) · Revista médica de Chile · doi:10.4067/s0034-98872013000400011 · Cited by 6
Church baptizes Joseph and Perry. Eccentric views absolved
Cole, G. M. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00214-1 · Cited by 4
COX-1, COX-2: So What?: EDITORIAL REVIEW
Emery, P. (1999) · Scandinavian Journal of Rheumatology · doi:10.1080/03009749950155715 · Cited by 4
Nonsteroidal antiinflammatory drugs as therapeutic agents for Alzheimer's disease
Golde, T. E., Eriksen, J. L., Weggen, S., Sagi, S. A., & Koo, E. H. (2002) · Drug Development Research · doi:10.1002/ddr.10093 · Cited by 4
Mecanismos neurobiológicos de la enfermedad de Alzheimer
Rommy von Bernhardi, M. (2005) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272005000200005 · Cited by 4
Metadata
- Authors
- Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Neurology
- Published
- 1997-03
- Volume
- 48
- Issue
- 3
- Pages
- 626-632
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2163110760
- Cited by
- 1,132
- References
- 16
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 13 · 2023: 22 · 2022: 19 · 2021: 22 · 2020: 23 · 2019: 22 · 2018: 21 · 2017: 24 · 2016: 28 · 2015: 29 · 2014: 32 · 2013: 24 · 2012: 31
- FWCI
- 42.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- American Academy of Neurology
- National Institutes of Health
- National Institute on Aging (R01AG008325, R01-AG08325)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Alzheimer's disease, nonsteroidal anti-inflammatory drugs, aspirin, paracetamol, medication use, neuroprotection, neuroinflammation
- MeSH terms
- Acetaminophen, Aged, Aged, 80 and over, Alzheimer Disease, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Confidence Intervals, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
